Samil Pharmaceutical Co.,Ltd (KRX: 000520)

Samil Pharmaceutical Co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,010	906.14	1,903	3,992	15,997	16,718
Short-Term Investments	-	-	-	11,269	1,200	13,032
Cash & Short-Term Investments	2,010	906.14	1,903	15,261	17,197	29,750
Cash Growth	1.22%	-52.40%	-87.53%	-11.26%	-42.19%	170.72%
Accounts Receivable	37,266	35,813	34,181	31,012	30,137	25,746
Other Receivables	292.9	86.62	123.85	120.23	57.85	526.21
Receivables	37,559	35,900	34,304	31,133	30,195	26,272
Inventory	31,184	32,511	24,742	24,177	24,084	22,413
Prepaid Expenses	11,798	-	-	-	767.79	330.34
Other Current Assets	2,143	11,797	13,832	6,140	279.56	434.11
Total Current Assets	84,694	81,115	74,781	76,711	72,523	79,200
Property, Plant & Equipment	247,722	242,198	233,946	103,394	64,808	71,902
Long-Term Investments	840.72	797.39	782.42	838.64	1,066	1,025
Other Intangible Assets	1,817	1,917	3,136	1,295	1,726	1,731
Long-Term Accounts Receivable	-0	0	0	0	0	0
Long-Term Deferred Tax Assets	-	-	-	-	1,927	-
Long-Term Deferred Charges	853.12	902.04	-	-	-	-
Other Long-Term Assets	43,532	43,750	44,054	44,167	49,610	30,017
Total Assets	379,459	370,680	356,700	226,405	191,661	183,875
Accounts Payable	16,587	21,004	13,660	8,541	10,826	9,130
Accrued Expenses	4,591	3,282	4,013	11,153	3,842	2,828
Short-Term Debt	45,387	73,490	80,562	75,733	57,356	47,545
Current Portion of Long-Term Debt	29,314	51,208	4,940	16,560	16,416	500.4
Current Portion of Leases	658.82	387.37	452.59	308.27	323.43	306.54
Current Income Taxes Payable	2,178	2,417	1,949	-	1,686	74.92
Current Unearned Revenue	224.79	112.34	179.99	171.28	171.02	169.8
Other Current Liabilities	15,342	16,774	26,836	9,208	8,064	7,601
Total Current Liabilities	114,281	168,675	132,592	121,674	98,684	68,156
Long-Term Debt	65,831	49,568	71,918	31,911	20,000	44,994
Long-Term Leases	1,359	1,225	1,387	1,003	306.55	285.97
Long-Term Unearned Revenue	11.93	36.38	66.15	222.65	385.44	547.83
Long-Term Deferred Tax Liabilities	8,370	9,752	13,172	-	-	-
Other Long-Term Liabilities	1,943	2,286	5,120	4,202	4,139	4,045
Total Liabilities	205,100	242,853	230,881	160,658	128,110	121,602
Common Stock	10,569	7,613	6,857	6,769	6,695	6,500
Additional Paid-In Capital	84,380	44,008	40,481	35,248	26,752	23,164
Retained Earnings	26,528	28,019	26,605	27,741	35,034	35,216
Treasury Stock	-2,517	-4,161	-4,142	-5,431	-3,765	-2,420
Comprehensive Income & Other	55,400	52,349	56,019	1,420	-1,164	-187.38
Shareholders' Equity	174,359	127,827	125,820	65,746	63,551	62,272
Total Liabilities & Equity	379,459	370,680	356,700	226,405	191,661	183,875
Total Debt	142,549	175,879	159,258	125,515	94,403	93,632
Net Cash (Debt)	-140,539	-174,973	-157,355	-110,254	-77,205	-63,882
Net Cash Per Share	-9088.34	-12135.18	-11286.13	-7972.68	-5741.73	-4756.82
Filing Date Shares Outstanding	20.67	14.46	14.25	13.77	13.77	13.48
Total Common Shares Outstanding	20.67	14.46	14.25	13.77	13.77	13.48
Working Capital	-29,587	-87,560	-57,811	-44,964	-26,160	11,044
Book Value Per Share	8433.37	8838.31	8830.45	4776.06	4616.27	4620.60
Tangible Book Value	172,542	125,911	122,683	64,451	61,825	60,541
Tangible Book Value Per Share	8345.48	8705.79	8610.32	4681.97	4490.90	4492.15
Land	64,487	64,487	67,149	2,501	2,578	14,492
Buildings	47,359	47,136	47,154	46,000	43,986	51,935
Machinery	43,891	44,846	43,178	44,758	42,591	39,143
Construction In Progress	138,851	132,199	120,009	55,341	22,792	12,050

Source: S&P Capital IQ. Standard template. Financial Sources.